RYTM

Rhythm Pharmaceuticals Inc. Common Stock (RYTM)

Stock · NASDAQ · Health Care

$107.17as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$87.24
Industry
Biotechnology: Pharmaceutical Preparations

How Rhythm Pharmaceuticals Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$189.76MSG&A$194.94M (103%)R&D$167.34M (88%)Cost of Revenue$19.49M (10%)Tax$497.0K (0%)RYTM

Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub

Rhythm Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • RYTM
    Rhythm Pharmaceuticals Inc. Common Stock
    $107.23
    ▼ 4.71%
    Market cap $7.04BP/E
  • COGT
    Cogent Biosciences Inc. Common Stock
    $34.68
    ▼ 6.50%
    Market cap $6.64BP/E
    $11.6$43.73
  • MIRM
    Mirum Pharmaceuticals Inc. Common Stock
    $97.44
    ▼ 2.32%
    Market cap $6.38BP/E
    $63.23$130
  • ERAS
    Erasca Inc. Common Stock
    $18.03
    ▼ 7.49%
    Market cap $6.11BP/E
    $1.33$24.28
  • BLTE
    Belite Bio Inc American Depositary Shares
    $151.65
    ▼ 3.42%
    Market cap $6.09BP/E
    $62.18$200
  • LGND
    Ligand Pharmaceuticals Incorporated Common Stock
    $280
    ▼ 1.59%
    Market cap $5.85BP/E 38.07
    $158.4$326.63
  • DNTH
    Dianthus Therapeutics Inc. Common Stock
    $105.72
    ▼ 5.22%
    Market cap $5.80BP/E
    $22.81$117.88

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
68.63M
Total value held
$5.82B
Institutional holders
279
Top holders this quarter
  • Unknown6.67M
  • Unknown6.24M
  • Unknown5.60M
  • Unknown3.42M
  • Unknown2.97M
  • Unknown2.37M
  • Unknown2.27M
  • Unknown1.97M
  • Unknown1.93M
  • Unknown1.69M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.